Patent · US Active

Use of nanodispersions in pharmaceutical end formulations

US7871642B2 · kind B2 · utility

4Cited by

14References

26Claims

0Family size

Assignees

Ciba Specialty Chemicals Corporation · US
Vesifact AG · CH

Inventors

Andreas Supersaxo · Baar, CH
Hans Georg Weder · Thalwil, CH
Dietmar Huglin · Eimeldingen, DE
Joachim Roding · Wiesbaden, DE

Key dates

Filing date	Jun 5, 2006
Grant date	Jan 18, 2011
Priority date	—
Expiry date	Sep 26, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P17/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A nanodispersion comprises The nanodispersions prepared according to this invention are suitable as transport vehicles for pharmaceutical active agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.